Page last updated: 2024-09-05

sorafenib and Focal Segmental Glomerulosclerosis

sorafenib has been researched along with Focal Segmental Glomerulosclerosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
El-Masry, M; Hanna, RM; Hasnain, H; Saab, S; Selamet, U; Wallace, WD; Wilson, J; Yanny, B	1
Audard, V; Bahleda, R; Baumelou, A; Bouachi, K; Bourry, E; Izzedine, H; Khayat, D; Lang, P; Mangier, M; Massard, C; Ollero, M; Ory, V; Pawlak, A; Péchoux, C; Sahali, D; Sendeyo, K; Soria, JC; Zhang, SY	1

Other Studies

2 other study(ies) available for sorafenib and Focal Segmental Glomerulosclerosis

Article	Year
Development of Focal Segmental Glomerulosclerosis and Thrombotic Microangiopathy in a Liver Transplant Patient on Sorafenib for Hepatocellular Carcinoma: A Case Report. Transplantation proceedings, 2018, Volume: 50, Issue:10 Topics: Acute Kidney Injury; Calcineurin Inhibitors; Carcinoma, Hepatocellular; Glomerulosclerosis, Focal Segmental; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Protein Kinase Inhibitors; Sorafenib; Thrombotic Microangiopathies; Transplantation, Homologous	2018
Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy. Kidney international, 2014, Volume: 85, Issue:2 Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Angiogenesis Inhibitors; Animals; Base Sequence; Binding Sites; Biomarkers; Carrier Proteins; Case-Control Studies; Cell Line; Female; Gene Expression Regulation; Glomerulosclerosis, Focal Segmental; Humans; Hypertension; Kidney Diseases; Kidney Glomerulus; Male; Mice; Mice, Knockout; Middle Aged; Molecular Sequence Data; Nephrosis, Lipoid; Niacinamide; Phenylurea Compounds; Predictive Value of Tests; Promoter Regions, Genetic; Protein Kinase Inhibitors; Proteinuria; Renal Insufficiency; Sorafenib; Thrombotic Microangiopathies; Transcription Factor RelA; Transcription, Genetic; Transfection; Vascular Endothelial Growth Factors; Young Adult	2014

Article

Year

Development of Focal Segmental Glomerulosclerosis and Thrombotic Microangiopathy in a Liver Transplant Patient on Sorafenib for Hepatocellular Carcinoma: A Case Report.

Transplantation proceedings, 2018, Volume: 50, Issue:10

Topics: Acute Kidney Injury; Calcineurin Inhibitors; Carcinoma, Hepatocellular; Glomerulosclerosis, Focal Segmental; Humans; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Protein Kinase Inhibitors; Sorafenib; Thrombotic Microangiopathies; Transplantation, Homologous

2018

Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy.

Kidney international, 2014, Volume: 85, Issue:2

Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Angiogenesis Inhibitors; Animals; Base Sequence; Binding Sites; Biomarkers; Carrier Proteins; Case-Control Studies; Cell Line; Female; Gene Expression Regulation; Glomerulosclerosis, Focal Segmental; Humans; Hypertension; Kidney Diseases; Kidney Glomerulus; Male; Mice; Mice, Knockout; Middle Aged; Molecular Sequence Data; Nephrosis, Lipoid; Niacinamide; Phenylurea Compounds; Predictive Value of Tests; Promoter Regions, Genetic; Protein Kinase Inhibitors; Proteinuria; Renal Insufficiency; Sorafenib; Thrombotic Microangiopathies; Transcription Factor RelA; Transcription, Genetic; Transfection; Vascular Endothelial Growth Factors; Young Adult

2014